BIOLASE Inc (NASDAQ:BIOL)

0.45
Delayed Data
As of Feb 16
 0.00 / 0.00%
Today’s Change
0.28
Today|||52-Week Range
1.57
+5.53%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$46.1M

Company Description

BIOLASE, Inc. is a medical technology company. It develops, manufactures, markets, and sells laser systems in dentistry and medicine and also markets, sells, and distributes dental imaging equipment, including cone beam digital x-rays and CAD/CAM intra-oral scanners, in-office, chair-side milling machines and three-dimensional printers. The company offers two categories of laser system products: Waterlase systems and Diode systems. Its flagship product category, the Waterlase system, uses a patented combination of water and laser to perform most procedures, performs using dental drills, scalpels and other traditional dental instruments for cutting soft and hard tissue. It also offers a family of Diode laser system products, including its ezlase soft tissue diode laser, to perform soft tissue and cosmetic procedures, including tooth whitening. The company also manufactures and sells accessories and disposables for its laser systems, such as hand pieces, laser tips and tooth whitening gel. BIOLASE was founded in 1987 and is headquartered in Irvine, CA.

Contact Information

BIOLASE, Inc.
4 Cromwell
Irvine California 92618
P:(888) 424-6527
Investor Relations:

Employees

Shareholders

Other institutional34.11%
Individual stakeholders27.96%
Mutual fund holders2.12%

Top Executives

Harold C. FlynnPresident, Chief Executive Officer & Director
Richard R. WhippVice President-Operations
John R. BeaverChief Financial Officer & Senior Vice President
Dmitri BoutoussovVice President-Research & Development
Samuel B. LowVP-Dental & Clinical Affairs & Chief Dental Office